arrow
Back
L

LiuMark (Lajos Pusztai)

yale

114H-index
1.4KPaper Count
6.8WCitation Count
Published Papers 417
Publication Date
Multi-modal AI for comprehensive breast cancer prognostication
err2026-05-20
err0
errOAAI
errJan Witowski; Ken G. Zeng; Joseph Cappadona; Jailan Elayoubi; Khalil Choucair; Elena Diana Chiru; Nancy Chan; Young-Joon Kang; Frederick Howard; Irina Ostrovnaya; Carlos Fernandez-Granda; Freya Schnabel; Zoe Steinsnyder; Ugur Ozerdem; Kangning Liu; Waleed Abdulsattar; Yu Zong; Lina Daoud; Rafic Beydoun; Anas M. Saad; Nitya Thakore; Mohammad Sadic; Frank Yeung; Elisa Liu; Theodore Hill; Benjamin Swett; Danielle Rigau; Andrew J. Clayburn; Valerie Speirs; Marcus Vetter; Lina Sojak; Simone Muenst; Daniel Baumhoer; Jia-Wern Pan; Haslina Makmur; Soo-Hwang Teo; Linda M. Pak; Victor Angel; Dovile Zilenaite-Petrulaitiene; Arvydas Laurinavicius; Natalie Klar; Brian D. Piening; Carlo Bifulco; Sun-Young Jun; Jae Pak Yi; Su Hyun Lim; Adam Brufsky; Francisco J. Esteva; Lajos Pusztai; Yann LeCun; Krzysztof J. Geras
errShare
errSave
Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase 3 trial
err2025-10-21
err0
errOAAI
errNadia Harbeck; Shanu Modi; Lajos Pusztai; Shinji Ohno; Jiong Wu; Sung-Bae Kim; Atsushi Yoshida; Alessandra Fabi; Xuchen Cao; Rona Joseph; Rubi Li; Bogdan Żurawski; Santiago Escrivá-de-Romaní; Renata Meneguetti; Archara Supavavej; Shin-Cheh Chen; Zhenzhen Liu; Catherine Kelly; Giuseppe Curigliano; William F. Symmans; Mohammad Gufran; Jun Ke; Adam Konpa; Pia Herbolsheimer; Jean-François Boileau
errShare
errSave
Plain language summary of publication: Comparing nivolumab and neoadjuvant chemotherapy with placebo and neoadjuvant chemotherapy in participants with newly diagnosed estrogen receptor-positive breast cancer in the CheckMate 7FL clinical trial
err2025-10-01
err0
PREAI
errLoi, Sherene; Salgado, Roberto; Curigliano, Giuseppe; Ivan Romero Diaz, Roberto; Delaloge, Suzette; Rojas Garcia, Carlos Ignacio; Kok, Marleen; Saura, Cristina; Harbeck, Nadia; Mittendorf, Elizabeth A.; Yardley, Denise A.; Suarez Zaizar, Alberto; Caminos, Facundo Rufino; Ungureanu, Andrei; Reinoso-Toledo, Joaquin G.; Guarneri, Valentina; Egle, Daniel; Ades, Felipe; Pacius, Misena; Chhibber, Aparna; Chandra, Rajalakshmi; Nathani, Raheel; Spires, Thomas; Qun Wu, Jenny; Pusztai, Lajos; Mcarthur, Heather
errShare
errSave
Tumor-specific major histocompatibility-II expression predicts pathological complete response to atezolizumab combined to chemotherapy in triple-negative breast cancer
err2025-09-29
err0
errOAAI
errJustin M. Balko; Luca Licata; Xiao Qian Wang; Matteo Dugo; Chiun-Sheng Huang; Daniel Egle; Begoña Bermejo; Claudio Zamagni; Marc Thill; Antonio Anton; Stefania Russo; Elena Sevillano; Eva Maria Ciruelos; Richard Greil; Vladimir Semiglazov; Marco Colleoni; Catherine M. Kelly; Gabriella Mariani; Lucia Del Mastro; Stefania Zambelli; Giulia Viale; Maurizio Callari; Giuseppe Viale; Lajos Pusztai; Luca Gianni; H. Raza Ali; Giampaolo Bianchini
errShare
errSave
Correction: Associations amongst genes, molecules, cells, and organs in breast cancer metastasis
err2025-09-19
err0
PREAI
errS. David Nathanson; Lothar C. Dieterich; Xiang H-F. Zhang; Dhananjay A. Chitale; Lajos Pusztai; Emma Reynaud; Yi-Hsuan Wu; Alejandro Ríos-Hoyo
errShare
errSave
Impact of Anthracyclines in Genomic High Risk, Node-Negative, HR-Positive/HER2-Negative Breast Cancer
err2025-09-17
err0
PREAI
errN. Chen; J.Q. Freeman; S. Yarlagadda; A. Atmakuri; K. Kalinsky; L. Pusztai; J.A. Sparano; D. Huo; R. Nanda; F.M. Howard
errShare
errSave
Clinical factors influencing retreatment with anti-PD-(L)1 therapies after treatment in early-stage cancers: a modified Delphi consensus study
err2025-05-26
err0
errOAAI
errPusztai, Lajos; Sondak, Vernon K.; Cappuzzo, Federico; Chouaid, Christos; Elder, Chris; Hirasawa, Yosuke; Ishida, Masaru; Jones, Robert; Lee, Seung Hyeun; Mizuno, Ryuichi; Nagata, Masayoshi; Okonji, David; Parente, Phillip; Shah, Bhavesh; Sun, Alexander; Ferreira, Dominihemberg; Spiteri, Carmel; Lauer, Andrea; Kaliasethi, Amrit; Kao, Carol; Kothari, Smita; Mckendrick, Jan
errShare
errSave
A comprehensive evaluation of diversity measures for TCR repertoire profiling
err2025-05-14
err0
errOAAI
errMika, Justyna; Polanska, Alicja; Blenman, Kim R. M.; Pusztai, Lajos; Polanska, Joanna; Candeias, Serge; Marczyk, Michal
errShare
errSave
Genomic alterations in normal breast tissues preceding breast cancer diagnosis
err2025-04-22
err0
errOAAI
errDai, Jiawei; Rozenblit, Mariya; Li, Xiaoyue; Shan, Naing Lin; Wang, Yueyue; Mane, Shrikant; Marczyk, Michal; Pusztai, Lajos
errShare
errSave
Identification of Nectin-2 as a Potential Novel Antibody Drug Conjugate Target in Breast Cancer
err2025-03-01
err0
PREAI
errShan, Naing Lin; Wang, Yueyue; Zhu, Xiaolong; Pusztai, Lajos; Zhan, Haiying
errShare
errSave
A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer
err2025-02-13
err0
errOAAI
errMukhtar, Rita A.; Gottipati, Soumya; Yau, Christina; Lopez-Tarruella, Sara; Earl, Helena; Hayward, Larry; Hiller, Louise; Osdoit, Marie; van der Noordaa, Marieke; de Croze, Diane; Hamy, Anne-Sophie; Lae, Marick; Reyal, Fabien; Sonke, Gabe S.; Steenbruggen, Tessa G.; van Seijen, Maartje; Wesseling, Jelle; Martin, Miguel; del Monte-Millan, Maria; Boughey, Judy C.; Goetz, Matthew P.; Hoskin, Tanya; Valero, Vicente; Edge, Stephen B.; Abraham, Jean E.; Bartlett, John M. S.; Caldas, Carlos; Dunn, Janet; Provenzano, Elena; Sammut, Stephen-John; Thomas, Jeremy S.; Graham, Ashley; Hall, Peter; Mackintosh, Lorna; Fan, Fang; Godwin, Andrew K.; Schwensen, Kelsey; Sharma, Priyanka; Demichele, Angela M.; Cole, Kimberly; Pusztai, Lajos; Kim, Mi-Ok; van 't Veer, Laura; Cameron, David; Esserman, Laura J.; Fraser Symmans, W.
errShare
errSave
Pathologic complete response (pCR) rates for patients with HRD/HER2L high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial
err2025-02-01
err2
PREAI
errHuppert, L. A.; Wolf, D.; Yau, C.; Brown-Swigart, L.; Hirst, G. L.; Isaacs, C.; Pusztai, L.; Pohlmann, P. R.; Demichele, A.; Shatsky, R.; Yee, D.; Thomas, A.; Nanda, R.; Perlmutter, J.; Heditsian, D.; Hylton, N.; Symmans, F.; van't Veer, L. J.; Esserman, L.; Rugo, H. S.
errShare
errSave
GABAA receptor π forms channels that stimulate ERK through a G-protein-dependent pathway
err2025-01-01
err0
PREAI
errWang, Yueyue; Zhang, Yalan; Li, Wenxue; Salovska, Barbora; Zhang, Jianan; Li, Tongqing; Li, Hengyi; Liu, Yansheng; Kaczmarek, Leonard K.; Pusztai, Lajos; Klein, Daryl E.
errShare
errSave
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial
err2024-11-29
err0
errOAAI
errRediti, Mattia; Venet, David; Joaquin Garcia, Andrea; Maetens, Marion; Vincent, Delphine; Majjaj, Samira; El-Abed, Sarra; Di Cosimo, Serena; Ueno, Takayuki; Izquierdo, Miguel; Piccart, Martine; Pusztai, Lajos; Loi, Sherene; Salgado, Roberto; Viale, Giuseppe; Rothe, Francoise; Sotiriou, Christos
errShare
errSave
Rare germline variants in cancer-relevant genes are associated with breast cancer risk in young women with high-risk family history
err2024-11-27
err0
PREAI
errRozenblit, Mariya; Qing, Tao; Ye, Yixuan; Zhao, Hongyu; Hofstatter, Erin; Singh, Vinit; Reisenbichler, Emily; Murray, Michael; Pusztai, Lajos
errShare
errSave
Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer
err2024-11-01
err0
errOAAI
errCampbell, Michael J.; Wolf, Denise M.; Yau, Christina; Brown-Swigart, Lamorna; Wulfkuhle, Julie; Gallagher, Isela R.; Zhu, Zelos; Bolen, Jennifer; Vandenberg, Scott; Hoyt, Clifford; Mori, Hidetoshi; Borowsky, Alexander; Sit, Laura; Perlmutter, Jane; Asare, Smita M.; Nanda, Rita; Liu, Minetta C.; Yee, Douglas; Demichele, Angela M.; Hylton, Nola M.; Pusztai, Lajos; Berry, Donald A.; Hirst, Gillian L.; Petricoin, Emanuel F.; van't Veer, Laura; Esserman, Laura
errShare
errSave
Trends in breast cancer-specific death by clinical stage at diagnoses between 2000 and 2017
err2024-09-30
err1
PREAI
errMarczyk, Michal; Kahn, Adriana; Silber, Andrea; Rosenblit, Mariya; Digiovanna, Michael P.; Lustberg, Maryam; Pusztai, Lajos
errShare
errSave
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial
err2024-09-14
err1
PREAI
errKhoury, Katia; Meisel, Jane L.; Yau, Christina; Rugo, Hope S.; Nanda, Rita; Davidian, Marie; Tsiatis, Butch; Chien, A. Jo; Wallace, Anne M.; Arora, Mili; Rozenblit, Mariya; Hershman, Dawn L.; Zimmer, Alexandra; Clark, Amy S.; Beckwith, Heather; Elias, Anthony D.; Stringer-Reasor, Erica; Boughey, Judy C.; Nangia, Chaitali; Vaklavas, Christos; Omene, Coral; Albain, Kathy S.; Kalinsky, Kevin M.; Isaacs, Claudine; Tseng, Jennifer; Torres, Evanthia T. Roussos; Thomas, Brittani; Thomas, Alexandra; Sanford, Amy; Balassanian, Ronald; Ewing, Cheryl; Yeung, Kay; Sauder, Candice; Sanft, Tara; Pusztai, Lajos; Trivedi, Meghna S.; Outhaythip, Ashton; Li, Wen; Onishi, Natsuko; Asare, Adam L.; Beineke, Philip; Norwood, Peter; Brown-Swigart, Lamorna; Hirst, Gillian L.; Matthews, Jeffrey B.; Moore, Brian; Symmans, W. Fraser; Price, Elissa; Beedle, Carolyn; Perlmutter, Jane; Pohlmann, Paula; Shatsky, Rebecca A.; Demichele, Angela; Yee, Douglas; van't Veer, Laura J.; Hylton, Nola M.; Esserman, Laura J.
errShare
errSave
Phosphoenolpyruvate carboxykinase-2 (PCK2) is a therapeutic target in triple-negative breast cancer
err2024-08-23
err1
PREAI
errGunasekharan, Vignesh; Lin, Hao-Kuen; Marczyk, Michal; Rios-Hoyo, Alejandro; Campos, Gerson Espinoza; Shan, Naing Lin; Ahmed, Mostafa; Umlauf, Sheila; Gareiss, Peter; Raaisa, Raaisa; Williams, Richard; Cardone, Rebecca; Siebel, Stephan; Kibbey, Richard; Surovtseva, Yulia V.; Pusztai, Lajos
errShare
errSave